{"id":"https://openalex.org/W2008534045","doi":"https://doi.org/10.1016/0014-2964(75)90172-3","title":"Cytotoxic sulphonamides designed for selective deposition in malignant tissue","display_name":"Cytotoxic sulphonamides designed for selective deposition in malignant tissue","publication_year":1975,"publication_date":"1975-11-01","ids":{"openalex":"https://openalex.org/W2008534045","doi":"https://doi.org/10.1016/0014-2964(75)90172-3","mag":"2008534045","pmid":"https://pubmed.ncbi.nlm.nih.gov/3417"},"language":"en","primary_location":{"id":"doi:10.1016/0014-2964(75)90172-3","doi":"https://doi.org/10.1016/0014-2964(75)90172-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2964(75)90172-3","pdf_url":null,"source":{"id":"https://openalex.org/S4210204293","display_name":"European Journal of Cancer (1965)","issn_l":"0014-2964","issn":["0014-2964","1879-2995"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320146","host_organization_name":"Pergamon Press","host_organization_lineage":["https://openalex.org/P4310320146"],"host_organization_lineage_names":["Pergamon Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer (1965)","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005075154","display_name":"G Abel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Abel","raw_affiliation_strings":["Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113780297","display_name":"T.A. Connors","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"T.A. Connors","raw_affiliation_strings":["Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053571204","display_name":"Phyllis M. Goddard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P. Goddard","raw_affiliation_strings":["Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087980773","display_name":"Henri Hoellinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210111631","display_name":"H\u00f4pital Fernand-Widal","ror":"https://ror.org/01zkyzz15","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210111631"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"H. Hoellinger","raw_affiliation_strings":["INSERM-Unit\u00e9 de Recherches de Toxicologie Exp\u00e9rimentale, H\u00f4pital F. Widal-200 rue du Faubourg Saint-Denis, 75010 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM-Unit\u00e9 de Recherches de Toxicologie Exp\u00e9rimentale, H\u00f4pital F. Widal-200 rue du Faubourg Saint-Denis, 75010 Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210111631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080865078","display_name":"Nguyen\u2010Hoang Nam","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210111631","display_name":"H\u00f4pital Fernand-Widal","ror":"https://ror.org/01zkyzz15","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210111631"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nguyen-Hoang-Nam","raw_affiliation_strings":["INSERM-Unit\u00e9 de Recherches de Toxicologie Exp\u00e9rimentale, H\u00f4pital F. Widal-200 rue du Faubourg Saint-Denis, 75010 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"INSERM-Unit\u00e9 de Recherches de Toxicologie Exp\u00e9rimentale, H\u00f4pital F. Widal-200 rue du Faubourg Saint-Denis, 75010 Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210111631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069850103","display_name":"LOUIS PICHAT","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"L. Pichat","raw_affiliation_strings":["Service des Mol\u00e9cules Marqu\u00e9es, C.E.N.-Saclay, B.P. No. 2, 91190, Gif-sur-Yvette, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service des Mol\u00e9cules Marqu\u00e9es, C.E.N.-Saclay, B.P. No. 2, 91190, Gif-sur-Yvette, France","institution_ids":["https://openalex.org/I4210128565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062501570","display_name":"Walter C. J. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"W.C.J. Ross","raw_affiliation_strings":["Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029019599","display_name":"Derry E. V. Wilman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D.E.V. Wilman","raw_affiliation_strings":["Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London SW3 6JB, England","institution_ids":["https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.057,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.72089437,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"11","first_page":"787","last_page":"793"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.3127000033855438,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.3127000033855438,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.21889999508857727,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.20149999856948853,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulfonamides","display_name":"sulfonamides","score":0.9490000009536743},{"id":"https://openalex.org/keywords/tumor-selectivity","display_name":"tumor selectivity","score":0.6159999966621399},{"id":"https://openalex.org/keywords/pka","display_name":"pKa","score":0.7799999713897705},{"id":"https://openalex.org/keywords/sulphamerazine","display_name":"sulphamerazine","score":0.9670000076293945},{"id":"https://openalex.org/keywords/sulfapyridine","display_name":"sulfapyridine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antitumour-activity","display_name":"antitumour activity","score":0.8539999723434448},{"id":"https://openalex.org/keywords/biological-half-life","display_name":"biological half-life","score":0.9589999914169312},{"id":"https://openalex.org/keywords/plasma-cell-tumor","display_name":"plasma cell tumor","score":0.7250000238418579},{"id":"https://openalex.org/keywords/cytotoxic-drugs","display_name":"cytotoxic drugs","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5605491399765015},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48683661222457886},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.48362910747528076},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.431209921836853},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4170008897781372},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3303028345108032},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3128148913383484},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31279727816581726},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24059057235717773},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.19282746315002441}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010954","descriptor_name":"Plasmacytoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010954","descriptor_name":"Plasmacytoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014226","descriptor_name":"Triazenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014226","descriptor_name":"Triazenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014227","descriptor_name":"Triazines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0014-2964(75)90172-3","doi":"https://doi.org/10.1016/0014-2964(75)90172-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0014-2964(75)90172-3","pdf_url":null,"source":{"id":"https://openalex.org/S4210204293","display_name":"European Journal of Cancer (1965)","issn_l":"0014-2964","issn":["0014-2964","1879-2995"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320146","host_organization_name":"Pergamon Press","host_organization_lineage":["https://openalex.org/P4310320146"],"host_organization_lineage_names":["Pergamon Press"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer (1965)","raw_type":"journal-article"},{"id":"pmid:3417","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3417","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1603422710","https://openalex.org/W1975712803","https://openalex.org/W2019003919","https://openalex.org/W2027205901","https://openalex.org/W2057021092","https://openalex.org/W2081390031"],"related_works":["https://openalex.org/W2085975578","https://openalex.org/W2050557338","https://openalex.org/W2411092513","https://openalex.org/W2014581804","https://openalex.org/W2159848001","https://openalex.org/W2009523965","https://openalex.org/W2399444110","https://openalex.org/W2078476693","https://openalex.org/W1971707549","https://openalex.org/W2092668038"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}